Devices/Safety Alert·openFDA/device

MINIMED 780G OUS SYSTEM BLE CONNECT 3.0 MMOL/L (MEDTRONIC PUERTO RICO OPERATIONS CO.) — Malfunction

MediumPublished May 31, 2026· AI-analyzed Jun 8, 2026View original FDA source

AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.

What happened

A malfunction was reported involving the MiniMed 780G OUS System BLE Connect 3.0 mmol/L, manufactured by Medtronic Puerto Rico Operations Co.

Who it affects

The report affects the manufacturer and regulatory/QA professionals responsible for the MiniMed 780G OUS system and related Bluetooth Low Energy (BLE) connectivity components.

Why it matters

The source characterizes the event as a malfunction rather than an injury, yet it indicates potential reliability issues with the device's connectivity or system integrity. As this involves an insulin management system, such malfunctions can lead to reporting obligations and may necessitate further data collection to evaluate the risk of therapeutic interruption.

Practical takeaway

Regulatory teams should ensure adverse event reporting systems are updated to capture this specific malfunction. QA departments should review field performance data for this device model to determine if the issue is isolated or represents a trend requiring CAPA investigation.

FDA source material

Event type: Malfunction. Device: MINIMED 780G OUS SYSTEM BLE CONNECT 3.0 MMOL/L by MEDTRONIC PUERTO RICO OPERATIONS CO..

Open in openFDA / FDA.gov

AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.

MINIMED 780G OUS SYSTEM BLE CONNECT 3.0 MMOL/L (MEDTRONIC PUERTO RICO OPERATIONS CO.) — Malfunction

More from Devices